These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The rebound of nasal resistance after decongestant used in nose]. Shen J; Huang X; Xiang J; Shu H Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428 [TBL] [Abstract][Full Text] [Related]
5. [Rhinitis medicamentosa]. Finsnes KA Tidsskr Nor Laegeforen; 1987 Jun; 107(17-18):1558-9. PubMed ID: 2440127 [No Abstract] [Full Text] [Related]
12. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants. Archontaki M; Symvoulakis EK; Hajiioannou JK; Stamou AK; Kastrinakis S; Bizaki AJ; Kyrmizakis DE B-ENT; 2009; 5(3):159-62. PubMed ID: 19902852 [TBL] [Abstract][Full Text] [Related]
13. Rhinitis medicamentosa: the forgotten factor in nasal obstruction. Mabry RL South Med J; 1982 Jul; 75(7):817-9. PubMed ID: 6178170 [TBL] [Abstract][Full Text] [Related]
15. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Graf P Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860 [TBL] [Abstract][Full Text] [Related]
16. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990 [TBL] [Abstract][Full Text] [Related]